Etoposide-mediated deregulation of the G2M checkpoint in myeloid leukaemic cell lines results in loss of cell survival

British Journal of Haematology

Volumn 119, Issue 4, 2002, Pages 956-964

  Higginbottom, Karen ^a   Cummings, Michele ^a   Newland, Adrian C ^a   Allen, Paul D ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Apoptosis; Cell cycle; Cyclin dependent kinase 1; Tyrosine phosphorylation

Indexed keywords

BCR ABL PROTEIN; ETOPOSIDE; TOXIN; TYROSINE;

APOPTOSIS; ARTICLE; BONE MARROW CULTURE; CELL ASSAY; CELL CYCLE; CELL LINE; CELL SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; HUMAN CELL; MYELOID LEUKEMIA; PREDICTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CDC2 PROTEIN KINASE; CELL CYCLE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ETOPOSIDE; G2 PHASE; HL-60 CELLS; HUMANS; K562 CELLS; LEUKEMIA, MYELOID; MITOSIS; NUCLEIC ACID SYNTHESIS INHIBITORS; PHOSPHORYLATION;

EID: 0036454440     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03977.x     Document Type: Article

References (36)

1. Bedi, A., Barber, J.P., Bedi, G.C., El-Deiry, W.S., Sideransky, D., Vala, M.S., Akhtar, A., Hilton, J. & Jones, R.J. (1995) BCR-ABL-mediated inhibition of apoptosis with delay of G2M transition after DNA damage: A mechanism of resistance to multiple anticancer agents. Blood, 86, 1148-1158.
2. Bi, S., Hughes, T., Bungey, J., Chase, A., de Fabritis, P. & Goldman, J.M. (1992) p53 in chronic myeloid leukemia cell lines. Leukemia, 6, 839-842.
3. Chan, T.A., Hermeking, H., Lengauer, C., Kinzler, K.W. & Vogelstein, B. (1999) 14-3-3 sigma is required to prevent mitotic catastrophe after DNA damage. Nature, 401, 616-620.
4. Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M.A., Lassota, P. & Traganos, F. (1992) Features of apoptotic cells measured by flow cytometry. Cytometry, 13, 795-808.
5. Dunphy, W.G. & Kumagai, A. (1991) The cdc25 protein contains an intrinsic phosphatase activity. Cell, 67, 189-196.
6. Elledge, S.J. (1996) Cell cycle checkpoints: Preventing an identity crisis. Science, 274, 1664-1672.
7. Gautier, J., Solomon, M.J., Booher, R.N., Bazan, J.F. & Kirschner, M.W. (1991) cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell, 67, 197-211.
8. Hagting, A., Karlsson, C., Clute, P., Jackman, M. & Pines, J. (1998) MPF localisation is controlled by nuclear export. EMBO Journal, 17, 4127-4138.
9. Jackman, M.R. & Pines, J.N. (1997) Cyclins and the G2/M transition. In: Checkpoint Controls and Cancer Vol. 29. (ed. by M.B. Kastan), pp. 47-73. Cold Spring Harbor Laboratory Press, Cold Spring Harbor: New York.
10. Jiang, X.R., Macey, M.G., Collins, P.W. & Newland, A.C. (1994) Characterisation and modulation of drug transport kinetics in K562.cl.6 daunorubicin resistant cell lines. British Journal of Haematology, 86, 547-554.
11. Jin, P., Hardy, S. & Morgan, D.O. (1998) Nuclear localisation of cyclin B1 controls mitotic entry after DNA damage. Journal of Cell Biology, 141, 875-885.
12. Cdc2 kinase activity is excluded from the nucleus during the radiation-induced G2 arrest in HeLa cells. Journal of Biological Chemistry, 274, 34779-34784.
13. Kaufmann, S.H., Desnoyers, S., Ottaviano, Y., Davidson, N.E. & Poirier, G.G. (1993) Specific proteolytic fragmentation of poly (ADP-ribose) polymerase: An early marker of chemotherapy induced apoptosis. Cancer Research, 53, 3976-3985.
14. Kaufman, W.K. (1998) Human topoisomerase II function, tyrosine phosphorylation and cell cycle checkpoints. Proceedings of the Society for Experimental Biology and Medicine, 217, 327-334.
15. Koeffler, H.P., Miller, C., Nicholoson, M.A., Ranyard, J. & Bosselman, R.A. (1986) Increased expression of p53 protein in human leukemic cell lines. Proceedings of the National Academy of Sciences of the United States of America, 83, 4035-4039.
16. Listovski, T., Zor, A., Laronne, A. & Brandeis, M. (2000) Cdk1 is essential for mammalian cyclosome/APC regulation. Experimental Cell Research, 255, 184-191.
17. Liu, F., Stanton, J.J., Wu, Z. & Piwnica-Worms, H. (1997) The human myt1 kinase preferentially phosphorylates Cdc2 on threonine 14 and localises to the endoplasmic reticulum and Golgi complex. Molecular Cell Biology, 17, 571-583.
18. Liu, Q., Guntuku, S., Cui, X.S., Matsuoka, S., Cortez, D., Tamai, K. & Luo, G. (2000) Chk1 is an essential kinase that is regulated by Atr and required for the DNA damage checkpoint. Genes and Development, 14, 1448-1459.
19. Lopez-Girona, A., Furnari, B., Mondesert, O. & Russell, P. (1999) Nuclear localisation of Cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature, 397, 172-175.
20. Lozzio, C.B. & Lozzio, B.B. (1975) Human chronic myelogenous leukemia cell line (K562) with positive Philadelphia chromosome. Blood, 45, 321-334.
21. McGahon, A.J., Bissonette, R., Schmitt, M., Cotter, K.M., Green, D.R. & Cotter, T.G. (1994) BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood, 83, 1179-1187.
22. Makino, K., Yu, D. & Hung, M.-C. (2001) Transcriptional upregulation and activation of p55Cdc via p34cdc2 in taxol-induced apoptosis. Oncogene, 20, 2537-2543.
23. Martins, L.M., Mesner, P.W., Kottke, T.J., Basi, G.S., Tung, J.S., Svingen, P.A., Madden, B.J., Takahashi, A., McCormick, D.J., Earnshaw, W.C. & Kaufman, S.H. (1997) Comparison of caspase activation and subcellular localisation in HL-60 and K562 cells undergoing etoposide-induced apoptosis. Blood, 90, 4283-4296.
24. Matsuoka, S., Huang, M. & Elledge, S.J. (1998) Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science, 282, 1893-1897.
25. Morgan, D.O. (1995) Principles of CDK regulation. Nature, 374, 131-134.
26. Mueller, P.R., Coleman, T.R., Kumagai, A. & Dunphy, W.G. (1995) Myt1: A membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine 14 and tyrosine 15. Science, 270, 86-90.
27. Murray, A.W. (1992) Creative blocks: Cell-cycle checkpoints and feedback controls. Nature, 359, 599-604.
28. Nishii, K., Kabarowski, J.H.S., Gibbons, D.L., Griffiths, S.D., Titley, I., Weidemann, L.M. & Greaves, M.F. (1996) ts BCR-ABL kinase activation confers increased resistance to genotoxic damage via cell cycle block. Oncogene, 13, 2225-2234.
29. Nurse, P. (1990) Universal control mechanism regulating onset of M-phase. Nature, 344, 503-508.
30. O'Connor, P.M. & Fan, S. (1996) DNA damage checkpoints: Implications for cancer therapy. In: Progress in Cell Cycle Research. Vol. 2. (ed. by L. Meijer, S. Guidet & L. Vogel), pp. 165-173. Plenum Press, New York.
31. Parker, L.L. & Piwnica-Worms, H. (1992) Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase. Science, 257, 1955-1957.
32. Peng, C.Y., Graves, P.R., Thoma, R.S., Wu, Z., Shaw, A.S. & Piwnica-Worms, H. (1997) Mitotic and G2 checkpoint control: Regulation of 14-3-3 protein binding by phosphorylation of cdc25C on serine-216. Science, 277, 1501-1505.
33. Sanchez, Y., Wong, C., Thoma, R.S., Richman, R., Wu, Z., Piwnica-Worms, H. & Elledge, S.J. (1997) Conservation of the Chk1 checkpoint pathway in mammals: Linkage of DNA damage to cdk regulation through cdc25. Science, 277, 1497-1501.
34. Sherr, C.J. (1996) Cancer cell cycle. Science, 274, 1672-1677.
35. Toyoshima, F., Moriguchi, T., Wada, A., Fukada, M. & Nishida, E. (1998) Nuclear export of cyclin B1 and its possible role in the DNA damage-induced G2 checkpoint. EMBO Journal, 17, 2728-2735.
36. Zeng, Y., Forbes, K.C., Wu, Z., Moreno, S., Piwnica-Worms, H. & Enoch, T. (1998) The replication checkpoint requires phosphorylation of the phosphatase Cdc25. Nature, 395, 507-510.